CliffBio
small molecule

BUPHENYL

SODIUM PHENYLBUTYRATE

Loss of exclusivity—loss of exclusivity
CompanyHORIZON THERAPEUTICS US HOLDING LLC

Drug detail

Brand nameBUPHENYL
Active ingredientSODIUM PHENYLBUTYRATE
Strength3GM/TEASPOONFUL
Dosage formPOWDER
RouteORAL
ModalitySmall molecule
FDA approvalApril 1996
Marketing statusDISCN

More from HORIZON THERAPEUTICS US HOLDING LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.